These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37675271)

  • 21. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Canfell K; Kim JJ; Brisson M; Keane A; Simms KT; Caruana M; Burger EA; Martin D; Nguyen DTN; Bénard É; Sy S; Regan C; Drolet M; Gingras G; Laprise JF; Torode J; Smith MA; Fidarova E; Trapani D; Bray F; Ilbawi A; Broutet N; Hutubessy R
    Lancet; 2020 Feb; 395(10224):591-603. PubMed ID: 32007142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global Perspectives on the Hepatitis B Vaccination: Challenges, Achievements, and the Road to Elimination by 2030.
    Al-Busafi SA; Alwassief A
    Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model - Tashkent, Uzbekistan, December 6, 2019-March 15, 2020.
    Dunn R; Musabaev E; Razavi H; Sadirova S; Bakieva S; Razavi-Shearer K; Brigida K; Kamili S; Averhoff F; Nasrullah M
    MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(34):1161-1165. PubMed ID: 32853186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning.
    Nayagam S; Chan P; Zhao K; Sicuri E; Wang X; Jia J; Wei L; Walsh N; Rodewald LE; Zhang G; Ailing W; Zhang L; Chang JH; Hou W; Qiu Y; Sui B; Xiao Y; Zhuang H; Thursz MR; Scano F; Low-Beer D; Schwartländer B; Wang Y; Hallett TB
    Clin Infect Dis; 2021 Mar; 72(5):743-752. PubMed ID: 32255486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimating the Year Each State in the United States Will Achieve the World Health Organization's Elimination Targets for Hepatitis C.
    Sulkowski M; Cheng WH; Marx S; Sanchez Gonzalez Y; Strezewski J; Reau N
    Adv Ther; 2021 Jan; 38(1):423-440. PubMed ID: 33145648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B.
    Jeng WJ; Papatheodoridis GV; Lok ASF
    Lancet; 2023 Mar; 401(10381):1039-1052. PubMed ID: 36774930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.
    Yang HI; Tseng TC; Liu J; Lee MH; Liu CJ; Su TH; Batrla-Utermann R; Chan HL; Kao JH; Chen CJ
    Clin Gastroenterol Hepatol; 2016 Mar; 14(3):461-468.e2. PubMed ID: 26598229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in mortality of liver disease due to hepatitis B in China from 1990 to 2019: findings from the Global Burden of Disease Study.
    Cao G; Liu J; Liu M
    Chin Med J (Engl); 2022 Sep; 135(17):2049-2055. PubMed ID: 36228164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The case for simplifying and using absolute targets for viral hepatitis elimination goals.
    Polaris Observatory Collaborators
    J Viral Hepat; 2021 Jan; 28(1):12-19. PubMed ID: 32979881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress Toward the Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Worldwide, 2016-2021.
    Khetsuriani N; Lesi O; Desai S; Armstrong PA; Tohme RA
    MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(30):958-963. PubMed ID: 35900928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Towards the elimination of hepatitis B and hepatocellular carcinoma.
    Spearman CW
    S Afr Med J; 2018 Aug; 108(8b):13-16. PubMed ID: 30182907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. China's efforts to shed its title of "Leader in liver disease".
    Li X; Xu WF
    Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A global investment framework for the elimination of hepatitis B.
    Howell J; Pedrana A; Schroeder SE; Scott N; Aufegger L; Atun R; Baptista-Leite R; Hirnschall G; 't Hoen E; Hutchinson SJ; Lazarus JV; Olufunmilayo L; Peck R; Sharma M; Sohn AH; Thompson A; Thursz M; Wilson D; Hellard M
    J Hepatol; 2021 Mar; 74(3):535-549. PubMed ID: 32971137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019.
    Veracruz N; Gish RG; Cheung R; Chitnis AS; Wong RJ
    J Viral Hepat; 2022 May; 29(5):352-365. PubMed ID: 35274406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating the impact of test-and-treat strategies on hepatitis B virus infection in China by using an age-structured mathematical model.
    Zu J; Li M; Zhuang G; Liang P; Cui F; Wang F; Zheng H; Liang X
    Medicine (Baltimore); 2018 Apr; 97(16):e0484. PubMed ID: 29668627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china.
    Zhao S; Xu Z; Lu Y
    Int J Epidemiol; 2000 Aug; 29(4):744-52. PubMed ID: 10922354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
    Grob PJ
    Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of immigration on hepatitis B burden in the United States: a modelling study.
    Razavi-Shearer D; Gamkrelidze I; Pan CQ; Razavi-Shearer K; Blach S; Estes C; Mooneyhan E; Razavi H
    Lancet Reg Health Am; 2023 Jun; 22():100516. PubMed ID: 37274551
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.